The Biotechnology Industry Organization

Presents a Luncheon Seminar:

From Biotechnology Innovation to Global Health Solutions: Solutions for Diseases Affecting Developing Countries

Wednesday, 07 November 2007

13h00 to 15h00

Pavilion of the Ecole Hôtelière de Genève
situated behind the Vieux Bois Restaurant, at 12 Avenue de la Paix

Geneva, Switzerland

Biotechnology innovation holds the promise of addressing many of the world’s most pressing challenges. Through biotechnological processes, biotechnology enterprises are developing innovative solutions in healthcare, industrial and environmental applications, and food and agriculture. These enterprises, which are in general small- and medium-sized companies, have spent tens of billions of dollars on the development of cutting edge products which are currently in various stages of development. Dozens of small- and medium-sized biotechnology companies are already engaged in the development of solutions applicable to diseases which disproportionately affect developing countries, and many more are on the verge of engagement.

A panel of experts will not only discuss the critical role of biotechnology in the development of these solutions, but also how companies can be incentivized to move into this area. The panel will discuss the composition of the biotechnology “ecosystem” and describe each player’s role in the process as well as the challenges they face. The group will also provide examples of successful public private partnerships and the workings of incentives useful in driving the development of global health solutions.

13:00 – 13h20

Welcome; guests are invited to partake of a light buffet before the program begins

13h20 -14:00

The role of universities in biotechnology product development and capacity building

Association of University Technology Managers:

Jana Tom, University of California Systems, and

Ted Roumel, University of Maryland Biotechnology Institute

14h00 - 14h45

Government’s role in developing solutions for diseases that disproportionately affect

developing countries

Mark Rohrbaugh, US National Institutes of Health Director of Office of Technology Transfer.

Eileen Yen, former director of the Sarawak Biodiversity Center in Malaysia

Professor Diran Makinde, Network Director, NEPAD Biosciences, West Africa Biosciences

Network (WABNet)

14:45 – 15:00

Summary and closing

RSVP: Ms. Patricia Natali, Sidley Austin LLP: (022 308 0005)